Granted Patent
B2
US 12,331,311 · App. 16/277,721 · Granted Jun 17, 2025
Protein modification of living cells using sortase
C12N5/0006A61K40/11A61K40/15A61K40/31A61K40/32A61K40/4257A61K40/4272A61K40/428A61K47/65A61K47/66A61K47/68C12N5/0636C12N5/0638C12N9/52C12Y304/2207
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Non-genetically engineered mammalian cells modified by sortase-mediated conjugation of an agent thereto are provided. Methods of conjugating agents to non-genetically engineered mammalian cells using sortase are provided. Methods of using the cells, e.g., for diagnostic and/or therapeutic purposes, are provided.
Claims (25)
1. A human cell having an agent linked thereto via a sortase recognition sequence, wherein the agent is linked to an endogenous, non-genetically engineered protein of the human cell, wherein the non-genetically engineered protein comprises an endogenous nucleophilic acceptor sequence to which the agent is linked via the sortase recognition sequence, wherein the human cell has not been genetically engineered to express a protein comprising a sortase recognition sequence or a nucleophilic acceptor sequence, and wherein the agent comprises a cytokine a costimulatory molecule, or an adjuvant, wherein the adjuvant is a CD40 ligand, a ligand of a TLR, a pathogen-derived molecular pattern (PAMP), a PAMP mimic, an immunostimulatory nucleic acid, or a cationic polymer.
2. The human cell of claim 1 , wherein the human cell is a cellular artificial antigen presenting cell (aAPC).
3. The human cell of claim 1 , wherein the human cell is a hematopoietic stem cell (HSC).
4. The human cell of claim 1 , wherein the human cell is a myeloid progenitor cell or a lymphoid progenitor cell.
5. The human cell of claim 1 , wherein the human cell is a red blood cell.
6. The human cell of claim 1 , wherein the human cell is selected from the group consisting of lymphocytes, monocytes, dendritic cells, macrophages, neutrophils, mast cells, eosinophils, basophils, and natural killer (NK) cells.
7. The human cell of claim 1 , wherein the agent comprises a costimulatory molecule.
8. The human cell of claim 7 , wherein the costimulatory molecule is a B7 molecule, an ICOS ligand, a TNF alpha family member, 4-1BBL, or OX40L.
9. The human cell of claim 7 , wherein the costimulatory molecule is 4-1BBL.
10. The human cell of claim 7 , wherein the costimulatory molecule is a molecule that binds to a CD28 family receptor, a molecule that binds to a CD2 family receptor, a molecule that binds to ICOS, a molecule that binds to CD27, or a molecule that binds to 4-1BB (CD137).
11. The human cell of claim 1 , wherein the agent comprises an adjuvant.
12. The human cell of claim 11 , wherein the adjuvant comprises a ligand of a TLR, and wherein the TLR is TLR3, TLR4, and/or TLR9.
13. The human cell of claim 11 , wherein the adjuvant comprises a cationic polymer, and wherein the cationic polymer is a poly(amino acid).
14. The human cell of claim 1 , wherein the agent comprises a cytokine.
15. The human cell of claim 14 , wherein the cytokine is an interleukin.
16. The human cell of claim 15 , wherein the interleukin is IL-15 or membrane-bound IL-15.
17. The human cell of claim 15 , and wherein the interleukin is IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-11, IL-12, IL-13, IL-14, membrane-bound IL-15, IL-15, IL-17, IL-21, IL-23, IL-27, IL-35, or IL-38.
18. The human cell of claim 14 , wherein the cytokine is a colony stimulating factor.
19. The human cell of claim 18 , wherein the colony stimulating factor is granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony-stimulating factor (GM-CSF), or macrophage colony-stimulating factor (M-CSF).
20. The human cell of claim 14 , wherein the cytokine is an interleukin, TNF-alpha, a colony stimulating factor, interferon alpha 2a, interferon alpha 2b, interferon beta-1a, interferon beta-1b, leukemia inhibitory factor (LIF), or oncostatin M.
21. The human cell of claim 1 , wherein the sortase recognition sequence comprises LPXTG, wherein X is any amino acid.
22. The human cell of claim 1 , wherein the human cell has not been genetically engineered to express a polypeptide comprising a sequence comprising one or more N-terminal glycines.
23. A method of modulating an immune response of a subject to an entity of interest, the method comprising administering to the subject the human cell of claim 1 .
24. A method of treating a subject in need of treatment for a disease, the method comprising administering to the subject the human cell of claim 1 .
25. The method of claim 24 , wherein the disease is an infectious disease, cancer, an autoimmune disease, an allergy, an inflammatory condition, or an immunodeficiency.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 19, 2019
From: PLOEGH, HIDDE L.; SWEE, LEE KIM
To: WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 048937/0920 →
Continuity (4)
Continuation
14890296
Provisional Application
61943094
· Feb 21, 2014
Provisional Application
61822092
· May 10, 2013
References Cited (250)
US 5670132A
· Griffiths et al.
· 1997
[cited by applicant]
US 5728369A
· Griffiths et al.
· 1998
[cited by applicant]
US 6960473B2
· Migliaccio et al.
· 2005
[cited by applicant]
US 8206979B2
· Giarratana et al.
· 2012
[cited by applicant]
US 8496912B2
· McBride et al.
· 2013
[cited by applicant]
US 8865875B2
· Liu et al.
· 2014
[cited by applicant]
US 8940501B2
· Ploegh et al.
· 2015
[cited by applicant]
US 9267127B2
· Liu et al.
· 2016
[cited by applicant]
US 9751945B2
· Ploegh et al.
· 2017
[cited by applicant]
US 9878045B2
· DiStefano
· 2018
[cited by applicant]
US 20020122768A1
· Liu et al.
· 2002
[cited by applicant]
US 20030022178A1
· Schneewind et al.
· 2003
[cited by applicant]
US 20100092470A1
· Bhatt et al.
· 2010
[cited by applicant]
US 20110070154A1
· Hyde
· 2011
[cited by examiner]
US 20110195068A1
· Langermann et al.
· 2011
[cited by applicant]
US 20140030697A1
· Ploegh et al.
· 2014
[cited by applicant]
US 20180346899A1
· Pasqual et al.
· 2018
[cited by applicant]
US 20200370016A1
· Lipsitz et al.
· 2020
[cited by applicant]
CN 102559600A
· 2012
[cited by examiner]
JP 2010115136A
· 2010
[cited by applicant]
WO WO200062804A2
· 2000
[cited by applicant]
WO WO2005051976A2
· 2005
[cited by applicant]
WO WO2010078376A2
· 2010
[cited by applicant]
WO WO2010087994A2
· 2010
[cited by applicant]
WO WO2011101468A1
· 2011
[cited by applicant]
WO WO2011133704A2
· 2011
[cited by applicant]
WO WO2012142659A1
· 2012
[cited by applicant]
WO WO2013003555A1
· 2013
[cited by applicant]
WO WO2013155526A2
· 2013
[cited by applicant]
WO WO2014183006A2
· 2014
[cited by applicant]
WO WO2015073746A2
· 2015
[cited by applicant]
WO WO2020243006A1
· 2020
[cited by applicant]
U.S. Appl. No. 16/140,384, filed Sep. 24, 2018, Ploegh et al.
[cited by applicant]
U.S. Appl. No. 16/054,382, filed Aug. 3, 2018, Pasqual et al.
[cited by applicant]
U.S. Appl. No. 16/381,654, filed Apr. 11, 2019, Swee et al.
[cited by applicant]
PCT/US2010/000274, Nov. 8, 2010, Invitation to Pay Additional Fees.
[cited by applicant]
PCT/US2010/000274, Dec. 22, 2010, International Search Report and Written Opinion.
[cited by applicant]
PCT/US2010/000274, Aug. 11, 2011, International Preliminary Report on Patentability.
[cited by applicant]
PCT/US2012/044584, Nov. 15, 2012, International Search Report and Written Opinion.
[cited by applicant]
EP 10736161.0, Nov. 30, 2012, Extended European Search Report.
[cited by applicant]
PCT/US2012/044584, Jan. 16, 2014, International Preliminary Report on Patentability.
[cited by applicant]
PCT/US2014/037554, Sep. 5, 2014, Invitation to Pay Additional Fees.
[cited by applicant]
PCT/US2014/037545, Oct. 27, 2014, International Search Report and Written Opinion.
[cited by applicant]
PCT/US2014/037554, Nov. 6, 2014, International Search Report and Written Opinion.
[cited by applicant]
EP 12804570.5, Nov. 26, 2014, Extended European Search Report.
[cited by applicant]
PCT/US14/65574, Mar. 20, 2015, Invitation to Pay Additional Fees.
[cited by applicant]
PCT/US14/65574, Jun. 4, 2015, International Search Report and Written Opinion.
[cited by applicant]
PCT/US2014/037554, Nov. 19, 2015, International Preliminary Report on Patentability.
[cited by applicant]
PCT/US2014/037545, Nov. 19, 2015, International Preliminary Report on Patentability.
[cited by applicant]
EP 14795120.6, Oct. 13, 2016, Extended European Search Report.
[cited by applicant]
EP 14795167.7, Nov. 9, 2016, Extended European Search Report.
[cited by applicant]
PCT/US2016/055074, Dec. 1, 2016, Invitation to Pay Additional Fees.
[cited by applicant]
PCT/US2016/055074, Feb. 6, 2017, International Search Report and Written Opinion.
[cited by applicant]
PCT/US2016/055074, Apr. 12, 2018, International Preliminary Report on Patentability.
[cited by applicant]
EP 16852806.5, Apr. 29, 2019, Extended European Search Report.
[cited by applicant]
Extended European Search Report, mailed Nov. 30, 2012, in connection with EP 10736161.0.
[cited by applicant]
Invitation to Pay Additional Fees, mailed Nov. 8, 2010, in connection with PCT/US2010/000274.
[cited by applicant]
International Search Report and Written Opinion, mailed Dec. 22, 2010, in connection with PCT/US2010/000274.
[cited by applicant]
International Preliminary Report on Patentability, mailed Aug. 11, 2011, in connection with PCT/US2010/000274.
[cited by applicant]
Extended European Search Report, mailed Nov. 26, 2014, in connection with EP 12804570.5.
[cited by applicant]
International Search Report and Written Opinion, mailed Nov. 15, 2012, in connection with PCT/US2012/044584.
[cited by applicant]
International Preliminary Report on Patentability, mailed Jan. 16, 2014, in connection with PCT/US2012/044584.
[cited by applicant]
Extended European Search Report, mailed Nov. 9, 2016, in connection with EP 14795167.7.
[cited by applicant]
Invitation to Pay Additional Fees, mailed Sep. 5, 2014, in connection with PCT/US2014/037554.
[cited by applicant]
International Search Report and Written Opinion, mailed Nov. 6, 2014, in connection with PCT/US2014/037554.
[cited by applicant]
International Preliminary Report on Patentability, mailed Nov. 19, 2015, in connection with PCT/US2014/037554.
[cited by applicant]
Extended European Search Report, mailed Oct. 13, 2016, in connection with EP 14795120.6.
[cited by applicant]
International Search Report and Written Opinion, mailed Oct. 27, 2014, in connection with PCT/US2014/037545.
[cited by applicant]
International Preliminary Report on Patentability, mailed Nov. 19, 2015, in connection with PCT/US2014/037545.
[cited by applicant]
Invitation to Pay Additional Fees, mailed Mar. 20, 2015, in connection with PCT/US14/65574.
[cited by applicant]
International Search Report and Written Opinion, mailed Jun. 4, 2015, in connection with PCT/US14/65574.
[cited by applicant]
International Preliminary Report on Patentability, mailed Apr. 12, 2018, in connection with PCT/US2016/055074.
[cited by applicant]
International Search Report and Written Opinion, mailed Feb. 6, 2017, in connection with PCT/US2016/055074.
[cited by applicant]
Invitation to Pay Additional Fees, mailed Dec. 1, 2016, in connection with PCT/US2016/055074.
[cited by applicant]
Extended European Search Report, mailed Apr. 29, 2019, in connection with EP 16852806.5.
[cited by applicant]
[No Author Listed] Creative Biolabs. Single Domain Antibody Library. Retrieved from at www.creative-biolabs.com/single-domain-antibody-library-service.html?gclid=eaiaiqobchminozno5qo3givibczch3uhqhneaayaiaaegk-sfd_bwe o…
[cited by applicant]
[No Author Listed], Fusion protein. Wikipedia. 7 pages Retrieved from https://en.wikipedia.org/Fusion_protein on Feb. 8, 2019.
[cited by applicant]
Ahlgren et al., Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine. J Nucl Med.May 2009;50(5):781-9. doi: 10.2967/…
[cited by applicant]
Antos et al., A straight path to circular proteins. J Biol Chem. Jun. 5, 2009;284(23):16028-36. Epub Apr. 9, 2009.
[cited by applicant]
Antos et al., Lipid modification of proteins through sortase-catalyzed transpeptidation. J Am Chem Soc. Dec. 3, 2008;130(48):16338-43.
[cited by applicant]
Antos et al., Site-specific N- and C-terminal labeling of a single polypeptide using sortases of different specificity. J Am Chem Soc. Aug. 12, 2009;131(31):10800-1. doi: 10.1021/ja902681k.
[cited by applicant]
Barnett et al., Differential recognition of surface proteins in
[cited by applicant]
Boonyarattanakalin et al., Synthesis of an artificial cell surface receptor that enables oligohistidine affinity tags to func-tion as metal-dependent cell-penetrating peptides. J Am Chem Soc. Mar. 18, 2006;128(14):4917.
[cited by applicant]
Chan et al., Covalent attachment of proteins to solid supports and surfaces via Sortase-mediated ligation. PLoS One. Nov. 14, 2007;2(11):e1164. 5 pages.
[cited by applicant]
Chang et al., Development and characterization of 89Zr-labeled panitumumab for immuno-positron emission tomographic imaging of the epidermal growth factor receptor. Mol Imaging. Jan.-Feb. 2013;12(1):17-27.
[cited by applicant]
Chen et al., A general strategy for the evolution of bond-forming enzymes using yeast display. Proc Natl Acad Sci U S A. Jul. 12, 2011;108(28):11399-404. doi: 10.1073/pnas.1101046108. Epub Jun. 22, 2011.
[cited by applicant]
Chudakov et al., Fluorescent proteins and their applications in imaging living cells and tissues.Physiol Rev. Jul. 2010;90(3):1103-63. doi: 10.1152/physrev.00038.2009.
[cited by applicant]
Clow et al., Immobilization of proteins to biacore sensor chips using
[cited by applicant]
De Meyer et al., Nanobody-based products as research and diagnostic tools. Trends Biotechnol. May 2014;32(5):263-70. doi: 10.1016/j.tibtech.2014.03.001. Epub Apr. 1, 2014.
[cited by applicant]
Delgado, et al. Stabilities of divalent and trivalent metal ion complexes of macrocyclic triazatriacetic acids. Inorg. Chem. 1999; 32, 3320-3326.
[cited by applicant]
Denk et al., Development of a (18) F-labeled tetrazine with favorable pharmacokinetics for bioorthogonal PET imaging. Angew Chem Int Ed Engl. Sep. 1, 2014;53(36):9655-9. doi:10.1002/anie.201404277. Epub Jul. 2, 2014.
[cited by applicant]
Dijkers et al., Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin Pharmacol Ther. May 2010;87(5):586-92. doi: 10.1038/clpt.2010.12. Epub Mar. 31…
[cited by applicant]
Dorr et al., Reprogramming the specificity of sortase enzymes. Proc Natl Acad Sci U S A. Sep. 16, 2014;111(37):13343-8. doi:10.1073/pnas.1411179111. Epub Sep. 3, 2014.
[cited by applicant]
Engfeldt et al., Chemical synthesis of triple-labelled three-helix bundle binding proteins for specific fluorescent detection of unlabelled protein. Chembiochem. Jun. 2005;6(6):1043-50.
[cited by applicant]
GenPept Accession No. YP 187332.1. Gill et al. Dec. 17, 2014.
[cited by applicant]
Goldenberg et al., Novel radiolabeled antibody conjugates. Oncogene. May 28, 2007;26(25):3734-44.
[cited by applicant]
Groheux et al., Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer. Eur J Nucl Med Mol Imaging. Mar. 2011;38(3):426-35. doi:10.1007/s00259-010-1640-9. Epub No…
[cited by applicant]
Hackenberger et al., Chemoselective ligation and modification strategies for peptides and proteins. Angew Chem Int Ed Engl. 2008;47(52):10030-74. doi: 10.1002/anie.200801313.
[cited by applicant]
Hochuli et al., Genetic Approach to Facilitate Purification of Recombinant Proteins with a Novel Metal Chelate Adsorbent. Nature Biotechnology. 1988, 6, 1321-1325.
[cited by applicant]
Holm et al., Electrophilic affibodies forming covalent bonds to protein targets. J Biol Chem. Nov. 20, 2009;284(47):32906-13. doi: 10.1074/jbc.M109.034322. Epub Sep. 15, 2009.
[cited by applicant]
Keliher et al., High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors. ChemMedChem. Mar. 7, 2011;6(3):424-7. doi: 10.1002/cmdc.201000426. Epub Jan. 4, 2011.
[cited by applicant]
Knowles et al., Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology. J Clin Oncol. Nov. 1, 2012;30(31):3884-92. doi: 10.1200/JCO.2012.42.4887. Epub Sep. 17, 2012.
[cited by applicant]
Kruger et al., Analysis of the substrate specificity of the
[cited by applicant]
Langenhan et al., Recent Carbohydrate-Based Chemoselective Ligation Applications. Current Organic Synthesis. 2005; 2, 59-81.
[cited by applicant]
Levary et al., Protein-protein fusion catalyzed by sortase A. PLoS One. Apr. 6, 2011;6(4):e18342. doi: 10.1371/journal.pone.0018342. 6 pages.
[cited by applicant]
Lu et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood. Dec. 1, 2008;112(12):4475-84. doi: 10.1182/blood-2008-05-157198. Epub Aug. 19, 2008.
[cited by applicant]
Lundberg et al., Site-specifically conjugated anti-HER2 Affibody molecules as one-step reagents for target expression analyses on cells and xenograft samples. J Immunol Methods. Jan. 30, 2007;319(1-2):53-63. Epub Nov. 2…
[cited by applicant]
Mao et al., Sortase-Mediated Protein Ligation: A New Method for Portein Engineering. J Am Chem Soc. Feb. 10, 2004;126:2670-1.
[cited by applicant]
Mao, A self-cleavable sortase fusion for one-step purification of free recombinant proteins. Protein Expr Purif. Sep. 2004;37(1):253-63.
[cited by applicant]
Maresso et al., Surface protein IsdC and Sortase B are required for heme-iron scavenging of Bacillus anthracis. J Bacteriol. Dec. 2006;188(23):8145-52. Epub Sep. 29, 2006.
[cited by applicant]
Mariscotti et al., The Listeria monocytogenes sortase-B recognizes varied amino acids at position 2 of the sorting motif. J Biol Chem. Mar. 6, 2009;284(10):6140-6. Epub Jan. 7, 2009.
[cited by applicant]
Marraffini et al., Sortase C-mediated anchoring of BasI to the cell wall envelope of Bacillus anthracis. J Bacteriol. Sep. 2007;189(17):6425-36. Epub Jun. 22, 2007.
[cited by applicant]
Matsumoto et al., Site-specific tetrameric streptavidin-protein conjugation using sortase A. J Biotechnol. Mar. 10, 2011;152(1-2):37-42. doi: 10.1016/j.jbiotec.2011.01.008. Epub Jan. 22, 2011.
[cited by applicant]
Matsumura et al., Emerging principles for the recognition of peptide antigens by MHC class 1 molecules, Sci. 1992;257:927-934.
[cited by applicant]
Mazmanian et al., An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis. Proc Natl Acad Sci U S A. Feb. 19, 2002;99(4):2293-8. Epub Feb. 5, 2002.
[cited by applicant]
Mazmanian et al., Sortase-catalysed anchoring of surface proteins to the cell wall of
[cited by applicant]
Moreno et al., Immunohistochemical analysis of B3 integrin (CD61 ):expression in pig tissues and human tumors. Histol Histopathol. 2002;17:347-352.
[cited by applicant]
Nair-Gill et al., Non-invasive imaging of adaptive immunity using positron emission tomography. Immunol Rev. Feb. 2008;221:214-28. doi: 10.1111/j.1600-065X.2008.00585.x.
[cited by applicant]
Namavari et al., A novel method for direct site-specific radiolabeling of peptides using [18F]FDG. Bioconjug Chem. Mar. 18, 2009;20(3):432-6. doi: 10.1021/bc800422b.
[cited by applicant]
Nayak et al., PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab. J Nucl Med. Jan. 2012;53(1):113-20. doi: 10.296…
[cited by applicant]
Ning et al., Visualizing metabolically labeled glycoconjugates of living cells by copper-free and fast huisgen cycloadditions. Angew Chem Int Ed Engl. 2008;47(12):2253-5.
[cited by applicant]
Orlova et al., Evaluation of [(111/114m)In]CHX-A″-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors. Q J Nucl Med Mol Imaging. 2007.
[cited by applicant]
Orlova et al., Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res. Apr. 15, 2006;66(8):4339-48.
[cited by applicant]
Pallen et al., An embarrassment of sortases—a richness of substrates? Trends Microbiol. Mar. 2001;9(3):97-101.
[cited by applicant]
Park et al., Anchoring foreign substances on live cell surfaces using Sortase A specific binding peptide. Chem Commun (Camb). Oct. 25, 2013;49(83):9585-7. doi: 10.1039/c3cc44753g.
[cited by applicant]
Parthasarathy et al., Sortase A as a novel molecular stapler for sequence-specific protein conjugation. Bioconjug Chem. Mar.-Apr. 2007;18(2):469-76. Epub Feb. 16, 2007.
[cited by applicant]
Paterson et al., Enzyme-mediated site-specific bioconjugation of metal complexes to proteins: sortase-mediated coupling of copper-64 to a single-chain antibody. Angew Chem Int Ed Engl. Jun. 10, 2014;53(24):6115-9. doi: …
[cited by applicant]
Pellois et al., A ligation and photorelease strategy for the temporal and spatial control of protein function in living cells. Angew Chem Int Ed Engl. Sep. 5, 2005;44(35):5713-7.
[cited by applicant]
Piotukh et al., D. Directed evolution of sortase A mutants with altered substrate selectivity profiles. J Am Chem Soc. Nov. 9, 2011;133(44):17536-9. doi: 10.1021/ja205630g. Epub Oct. 13, 2011.
[cited by applicant]
Pishesha et al., Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. Proc Natl Acad Sci U S A. Mar. 21, 2017;114(12):3157-3162. doi:10.1073/pnas.1701746114. Epub Mar. …
[cited by applicant]
Poli et al., Radretumab radioimmunotherapy in patients with brain metastasis: a 124I-L19SIP dosimetric PET study. Cancer Immunol Res. Aug. 2013;1(2):134-43. doi: 10.1158/2326-6066.CIR-13-0007. Epub May 20, 2013.
[cited by applicant]
Popp et al., Making and breaking peptide bonds: protein engineering using sortase. Angew Chem Int Ed Engl. May 23, 2011;50(22):5024-32. doi: 10.1002/anie.201008267. Epub Apr. 27, 2011.
[cited by applicant]
Popp et al., Site-specific protein labeling via sortase-mediated transpeptidation. Curr Protoc Protein Sci. Apr. 2009;Chapter 15:Unit 15.3. doi: 10.1002/0471140864.ps1503s56.
[cited by applicant]
Popp et al., Sortagging: a versatile method for protein labeling. Nat Chem Biol. Nov. 2007;3(11):707-8. Epub Sep. 23, 2007.
[cited by applicant]
Popp et al., Sortase-catalyzed transformations that improve the properties of cytokines. Proc Natl Acad Sci USA. Feb. 22, 2011;108(8):3169-74. doi: 10.1073/pnas.1016863108. Epub Feb. 4, 2011.
[cited by applicant]
Popp et al., Substrate filtering by the active site crossover loop in UCHL3 revealed by sortagging and gain-of-function mutations. J Biol Chem. Feb. 6, 2009;284(6):3593-602. Epub Dec. 1, 2008.
[cited by applicant]
Rashidian et al., A highly efficient catalyst for oxime ligation and hydrazone-oxime exchange suitable for bioconjugation. Bioconjug Chem. Mar. 20, 2013;24(3):333-42. doi: 10.1021/bc3004167.Epub Mar. 6, 2013.
[cited by applicant]
Rashidian et al., Enzymatic labeling of proteins: techniques and approaches. Bioconjug Chem. Aug. 21, 2013;24(8):1277-94.
[cited by applicant]
Salsano et al., PET imaging using radiolabeled antibodies: future direction in tumor diagnosis and correlate applications. Research and Reports in Nuclear Medicine. 2013: 3; 9-17.
[cited by applicant]
Samantaray et al., Peptide-sugar ligation catalyzed by transpeptidase sortase: a facile approach to neoglycoconjugate synthesis. J Am Chem Soc. Feb. 20, 2008;130(7):2132-3. Epub Jan. 30, 2008.
[cited by applicant]
Shi et al. Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes. Proc Natl Acad Sci U S A. Jul. 15, 2014;111(28):10131-6. doi: 10.1073/pnas.1409861111. Epub Jun. 30, 2014.
[cited by applicant]
Siontorou, Nanobodies as novel agents for disease diagnosis and therapy. Int J Nanomedicine. 2013;8:4215-27. doi: 10.2147/IJN.S39428. Epub Jan. 11, 2013.
[cited by applicant]
Spicer et al., Selective chemical protein modification. Nat Commun. Sep. 5, 2014;5:4740. doi: 10.1038/ncomms5740.
[cited by applicant]
Strijbis et al., Protein ligation in living cells using sortase. Traffic. Jun. 2012;13(6):780-9. doi: 10.1111/j.1600-0854.2012.01345.x. Epub Mar. 23, 2012.
[cited by applicant]
Swee et al., One-step enzymatic modification of the cell surface redirects cellular cytotoxicity and parasite tropism. ACS Chem Biol. Feb. 20, 2015;10(2):460-5. doi: 10.1021/cb500462t.
[cited by applicant]
Swee et al., Sortase-mediated modification of αDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes. Proc Natl Acad Sci USA. Jan. 22, 2013;110(4):1428-33. doi: 10.1073/pna…
[cited by applicant]
Ta et al., Enzymatic single-chain antibody tagging: a universal approach to targeted molecular imaging and cell homing in cardiovascular disease. Circ Res. Aug. 5, 2011;109(4):365-73. doi: 10.1161/CIRCRESAHA.111.249375.
[cited by applicant]
Tanaka et al., PET (positron emission tomography) imaging of biomolecules using metal-DOTA complexes: a new collaborative challenge by chemists, biologists, and physicians for future diagnostics and exploration of in vi…
[cited by applicant]
Tanaka et al., Site-specific protein modification on living cells catalyzed by Sortase. Chembiochem. Mar. 25, 2008;9(5):802-7.
[cited by applicant]
Theile et al., Site-specific N-terminal labeling of proteins using sortase-mediated reactions. Nat Protoc. Sep. 2013;8(9):1800-7. doi: 10.1038/nprot.2013.102. Epub Aug. 29, 2013.
[cited by applicant]
Tolmachev et al., Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule. Cancer Res. Mar. 15, 2007;67(6):2773-82.
[cited by applicant]
Ton-That et al., Anchoring of surface proteins to the cell wall of
[cited by applicant]
Ton-That et al., Protein sorting to the cell wall envelope of Gram-positive bacteria. Biochim Biophys Acta. Nov. 11, 2004;1694(1-3):269-78.
[cited by applicant]
Ton-That et al., Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of
[cited by applicant]
Tran et al., (99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors. Bioconjug Chem. Nov.-Dec. 2007;18(6):1956-64. Epub Oct. 19, 2007.
[cited by applicant]
Truong et al., Copper-catalyzed, directing group-assisted fluorination of arene and heteroarene C-H bonds. J Am Chem Soc. Jun. 26, 2013;135(25):9342-5. doi: 10.1021/ja4047125. Epub Jun. 12, 2013.
[cited by applicant]
Tsukiji et al., Sortase-mediated ligation: A Gift from Gram-Positive Bacteria to Protein Engineering, ChemBioChem 2009;10:787-798.
[cited by applicant]
Vaidyanathan et al., Synthesis of N-succinimidyl 4-[18F]fluorobenzoate, an agent for labeling proteins and peptides with 18F. Nat Protoc. 2006;1(4):1655-61.
[cited by applicant]
Vosjan et al., Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine. Nat Protoc. Apr. 2010;5(4):739-43. doi: 10.1…
[cited by applicant]
Waldherr et al., Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3′-deoxy-3′-18F-fluorothymidine Pet. J Nucl Med. Jan. 2005;46(1):114-20.
[cited by applicant]
Witte et al., Preparation of unnatural N-to-N and C-to-C protein fusions. Proc Natl Acad Sci U S A. Jul. 24, 2012;109(30):11993-8. doi: 10.1073/pnas.1205427109. Epub Jul. 9, 2012.
[cited by applicant]
Witte et al., Production of unnaturally linked chimeric proteins using a combination of sortase-catalyzed transpeptidation and click chemistry. Nat Protoc. Sep. 2013;8(9):1808-19. doi: 10.1038/nprot.2013.103. Epub Apr. …
[cited by applicant]
Wriggers et al., Control of Protein Functional Dynamics by Peptide Linkers, Prat. Function. Dynam. 2005;80:736-746.
[cited by applicant]
Wu et al., Sortase A-catalyzed transpeptidation of glycosylphosphatidylinositol derivatives for chemoenzymatic synthesis of GPI-anchored proteins. J Am Chem Soc. Feb. 10, 2010;132(5):1567-71. doi: 10.1021/ja906611x.
[cited by applicant]
Wu et al., The use of sortase-mediated ligation for the immobilisation of bacterial adhesins onto fluorescence-labelled microspheres: a novel approach to analyse bacterial adhesion to host cells. Biotechnol Lett. Nov. 2…
[cited by applicant]
Xiao et al., Protein N-terminal processing: substrate specificity of
[cited by applicant]
Yamamoto et al., Expansion of the sortase-mediated labeling method for site-specific N-terminal labeling of cell surface proteins on living cells. Chem Commun (Camb). Mar. 7, 2009;(9):1022-4. doi: 10.1039/b818792d. Epub…
[cited by applicant]
Youssef et al., The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med. Feb. 2012;53(2):241-8. doi:10.2967/jnumed.111.090662. Ep…
[cited by applicant]
Zhang et al., Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to Dota. PLoS One. 2011;6(12):e28005. doi:10.1371/journal.pone.0028005. Epub Dec. 9, 2011.
[cited by applicant]
Zong et al., Crystal structures of
[cited by applicant]
[No_Author_Listed] Polyethylene Glycol (PEG) and PEGylation of Proteins. ThermoFisher Scientific 2019. 11 pages.
[cited by applicant]
Bundy et al., Site-specific incorporation of p-propargyloxyphenylalanine in a cell-free ennvironment for direct protein-protein click conjugation. Bioconjug Chem. Feb. 17, 2010;21(2):255-63.
[cited by applicant]
Cheung et al., A small-scale serum-free liquid cell culture model of erythropoiesis to assess the effects of exogenous factors. J Immunol Methods. Jan. 30, 2007;319(1-2):104-17. Epub Dec. 4, 2006.
[cited by applicant]
Cooper et al., Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability. Bioconjug Chem. May 16, 2012;23(5):1029-39. doi: …
[cited by applicant]
David et al., Facile, efficient routes to diverse protected thiols and to their deprotection and addition to create functional polymers by thiol-ene coupling. Macromolec. 2008;41(4):1151-61.
[cited by applicant]
De Groeve et al., Nanobodies as tools for in vivo imaging of specific immune cell types. J Nucl Med. 2010;51(5):782-789. doi:10.2967/jnumed.109.070078.
[cited by applicant]
De Marco, User-friendly expression plasmids enable the fusion of VHHs to application-specific tags. Methods Mol Biol. 2012;911:507?522. doi: 10.1007/978-1-61779-968-6_32.
[cited by applicant]
Debets et al., Aza-dibenzocyclooctynes for fast and efficient enzyme PEGylation via copper-free (3+2) cycloaddition. Chem Commun (Camb). Jan. 7, 2010;46(1):97-9. doi: 10.1039/b917797c. Epub Nov. 6, 2009.
[cited by applicant]
Debierre-Grockiego et al., Differential effect of dexamethasone on cell death and STAT5 activation during in vitro eosinopoiesis. Br J Haematol. Dec. 2003;123(5):933-41. doi: 10.1046/j.1365-2141.2003.04700.x.
[cited by applicant]
Diamandis et al., The Biotin-(Strept) Avidin System: Principles and Applications in Biotechnology. Clin. Chem. 1991;37(5):625-36.
[cited by applicant]
Dorn et al., In vitro proliferation and differentiation of human CD34+ cells from peripheral blood into mature red blood cells with two different cell culture systems. Transfusion. Jun. 2008;48(6):1122-32. doi: 10.1111/…
[cited by applicant]
Fournier et al., Clicking polymers: a straightforward approach to novel macromolecular architectures. Chem Soc Rev. Aug. 2007;36(8):1369-80. Epub May 3, 2007.
[cited by applicant]
Hess et al., M13 bacteriophage display framework that allows sortase-mediated modification of surface-accessible phage proteins. Bioconjug Chem. Jul. 18, 2012;23(7):1478-87. doi: 10.1021/bc300130z. Epub Jul. 3, 2012.
[cited by applicant]
Hirakawa et al., Design of Ca2+-independent
[cited by applicant]
Idoyaga et al., Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc Natl Acad Sci U S A. Feb. 8, 2011;108(6):2384-9…
[cited by applicant]
Jevsevar et al., PEGylation of therapeutic proteins. Biotechnol J. Jan. 2010;5(1):113-28.
[cited by applicant]
Jokerst et al., Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond). 2011;6(4):715-728. doi:10.2217/nnm.11.19.
[cited by applicant]
Kijanka et al., Nanobody-based cancer therapy of solid tumors. Nanomedicine (Lond). Jan. 2015;10(1):161-74. doi: 10.2217/nnm.14.178.
[cited by applicant]
Kolb et al., The growing impact of click chemistry on drug discovery. Drug Discov Today. Dec. 15, 2003;8(24):1128-37.
[cited by applicant]
Kubetzko et al., PEGylation and multimerization of the anti-p185HER-2 single chain Fv fragment 4D5: effects on tumor targeting. J Biol Chem. 2006;281(46):35186-35201. doi:10.1074/jbc.M604127200.
[cited by applicant]
Li et al., Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments. Mol Cancer Ther. Nov. 2014;13(11):2607-17. doi: 10.1158/1535-7163.MCT-14-0363. Epub Aug. 20, 2014.
[cited by applicant]
Lowrie et al., Chapter 20. EPO: Treating Anemia in Chronic Renal Failure. The National Kidney Foundation. 2011;1-6.
[cited by applicant]
Miharada et al., Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol. Oct. 2006;24(10):1255-6. Epub Sep. 17, 2006.
[cited by applicant]
Pritz et al., Synthesis of biologically active peptide nucleic acid-peptide conjugates by sortase-mediated ligation. J Org Chem. May 11, 2007;72(10):3909-12. Epub Apr. 14, 2007.
[cited by applicant]
Race et al., Crystal structure of
[cited by applicant]
Reese et al. Human mesenchymal stem cells provide stromal support for efficient CD34+ transduction. J Hematother Stem Cell Res. Oct. 1999;8(5):515-23. doi: 10.1089/152581699319966.
[cited by applicant]
Sharpless et al., Just click it: Undergraduate procedures for the copper(I)-catalyzed formation of 1,2,3-triazoles from azides and terminal acetylenes. J Chem Ed. 2005;82(12):1833-6.
[cited by applicant]
Vosjan et al., Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET. Eur J Nucl Med Mol Imaging. 2011;38(4):753-763. doi:10.1007/s00259…
[cited by applicant]
Wu, F-18 Labeled Diabody-Luciferase Fusion Proteins for Optical-ImmunoPET. Department of Energy Final Scientific/Technical Report. Report No. DOE/SC0001220-1. University of California, Los Angeles. Jan. 18, 2013. doi: 1…
[cited by applicant]
Xavier et al., Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer. J Nucl Med. 2013;54(5):776-784. doi: 10.2967/jnumed.112…
[cited by applicant]
Zaslavskaia et al., Trophic conversion of an obligate photoautotrophic organism through metabolic engineering. Science. Jun. 15, 2001;292(5524):2073-5.
[cited by applicant]
Zhao et al., An efficient on-col. expressed protein ligation strategy: application to segmental triple labeling of human apolipoprotein E3. Protein Sci. Apr. 2008;17(4):736-47. Epub Feb. 27, 2008.
[cited by applicant]
Extended European Search Report, mailed Jul. 26, 2019, in connection with EP 19171188.6.
[cited by applicant]
Extended European Search Report, mailed Jul. 26, 2019, in connection with EP 19171190.2.
[cited by applicant]
Extended European Search Report, mailed Jun. 19, 2020 for Application No. EP 19219550.1.
[cited by applicant]
Deshayes et al., Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol Life Sci. Aug. 2005;62(16):1839-49. doi: 10.1007/s00018-005-5109-0.
[cited by applicant]
Marsden et al., Model systems for membrane fusion. Chem Soc Rev. Mar. 2011;40(3):1572-85. doi: 10.1039/c0cs00115e. Epub Dec. 13, 2010.
[cited by applicant]
Perez-Medina et al., A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting. J Nucl Med. Oct. 2014;55(10):1706-11. doi: 10.2967/jnumed.114.141861. Epub Jul. 24…
[cited by applicant]
Trilling et al., Orientation of llama antibodies strongly increases sensitivity of biosensors. Biosens Bioelectron. Oct. 15, 2014;60:130-6. doi: 10.1016/j.bios.2014.04.017. Epub Apr. 18, 2014.
[cited by applicant]
Wang et al., Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles. Proc Natl Acad Sci U S A. Mar. 15, 2016;113(11):2868-73. doi: 10.1073/pnas.1520244113. Epub Feb. 29, 2016.
[cited by applicant]
Warden-Rothman et al., Sortase-tag expressed protein ligation: combining protein purification and site-specific bioconjugation into a single step. Anal Chem. Nov. 19, 2013;85(22):11090-7. doi: 10.1021/ac402871k. Epub Oc…
[cited by applicant]
Wu et al., Sortase-Mediated Transpeptidation for Site-Specific Modification of Peptides, Glycopeptides, and Proteins. J Carbohydr Chem. 2012;31(1):48-66.
[cited by applicant]
Extended European Search Report, mailed Dec. 15, 2022, in connection with EP 22173120.1.
[cited by applicant]
Fishburn, C.S., The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics. J Pharm Sci. Oct. 2008;97(10):4167-83. doi: 10.1002/jps.21278.
[cited by applicant]
Kolate et al., PEG—a versatile conjugating ligand for drugs and drug delivery systems. J Control Release. Oct. 28, 2014;192:67-81. doi: 10.1016/j.jconrel.2014.06.046. Epub Jul. 2, 2014.
[cited by applicant]
Leong et al., Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylation. Cytokine. Nov. 7, 2001;16(3):106-19. doi: 10.1006/cyto.2001.0936.
[cited by applicant]
Pepinsky et al., Production of a PEGylated Fab' of the anti-LINGO-1 Li33 antibody and assessment of its biochemical and functional properties in vitro and in a rat model of remyelination. Bioconjug Chem. Feb. 16, 2011;2…
[cited by applicant]
Extended European Search Report, mailed Jun. 26, 2023, in connection with EP 16852806.5.
[cited by applicant]